Brief: Sumitomo Pharma and Pfizer in Canada Receive Health Canada Approval for MYFEMBREE
19/10/2023 12:44
Oct 19 (Reuters) - Pfizer Inc PFE.N :
* SUMITOMO PHARMA AND PFIZER IN CANADA RECEIVE HEALTH CANADA
APPROVAL FOR MYFEMBREE®
* SUMITOMO PHARMA AND PFIZER IN CANADA RECEIVE HEALTH CANADA
APPROVAL FOR MYFEMBREE®
* SUMITOMO PHARMA AMERICA: PFIZER CANADA WILL LEAD
COMMERCIALIZATION EFFORTS OF MYFEMBREE IN UTERINE FIBROID AND
ENDOMETRIOSIS INDICATIONS
Source text for Eikon: ID:nPnbQSs2za
Further company coverage: PFE.N
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Sumitomo Pharma
See all newsSumitomo Pharma America Announces First Patient Receives Treatment In Phase 1/2A Study For Investigational Therapy Dsp-3077 For Retinitis Pigmentosa
Regarding A Report Concerning Sumitomo Pharma ( Company's Views On Gcr August 7 Report)
Brief: Sumitomo Pharma - Gotham City Research's August 3 Report Contains Numerous Statements That Are Clearly Inconsistent With Facts
Brief: Gotham City Research Holds Short Positions In Sumitomo Chemical And Sumitomo Pharmaceutical
Table: Sumitomo Pharma -Q1 group results (IFRS)